53 results
D
SLNO
Soleno Therapeutics Inc
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
with the state, federal and foreign Health Care Laws applicable to the Company’s and the Subsidiaries’ respective businesses, and the Company … and the Subsidiaries are in compliance with such applicable Health Care Laws, except where the failure to do so could not reasonably be expected to have
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
course of federal or state health care legislation or foreign regulations relating to the marketing, pricing and reimbursement of pharmaceutical products … or conceal an obligation to pay money to the federal government;
S-42
HIPAA established the federal offense of health care fraud, which among other things
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
the future course of federal or state health care legislation or foreign regulations relating to the marketing, pricing and reimbursement … , decrease or conceal an obligation to pay money to the federal government;
S-42
HIPAA established the federal offense of health care fraud, which among
8-K
EX-1.1
tvg6uwxu
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
gj59wr
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
tirqup
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
ggc 7p0xgz3fi6a44
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
3f35s
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
di4uw gbzl
23 Jun 20
Prospectus supplement for primary offering
4:06pm